Invicta Diagnostic Limited (NSE:INVICTA)
97.35
+9.95 (11.38%)
At close: Apr 28, 2026
-2.65% (1Y)
| Market Cap | 1.22B |
| Revenue (ttm) | 301.81M |
| Net Income (ttm) | 48.92M |
| Shares Out | 12.57M |
| EPS (ttm) | 5.81 |
| PE Ratio | 16.75 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 168,000 |
| Average Volume | 29,200 |
| Open | 87.00 |
| Previous Close | 87.40 |
| Day's Range | 87.00 - 100.00 |
| 52-Week Range | 58.10 - 105.00 |
| Beta | n/a |
| RSI | 73.26 |
| Earnings Date | Jul 3, 2026 |